Brief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain
NCT ID: NCT05535335
Last Updated: 2022-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
364 participants
OBSERVATIONAL
2020-06-06
2022-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain.
NCT04235218
Reliability and Responsiveness of One Questionnaire Used on a Low Back Pain Population
NCT02892656
The Effect of Structured Pain Education on Pain and Performance Parameters in Patients With Chronic Low Back Pain
NCT05331274
Pain Management for Patients With Low Back Pain and Psychosocial Risk Factors in a Hospital Setting.
NCT03141541
Pain Types and Pain Severity in Chronic Low Back Pain
NCT05604027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study:
Participants:
Patients with chronic low back pain admitted to the Pain Centre after June 2021 at ZUHK.
* Persons ≥18 years
* Persons who suffers from chronic back pain and are admitted to the Pain Centre at Zealand University Hospital in Køge, Denmark
* Persons who have completed the BIPQ both at first and at last visit in the Pain Centre
Numbers 100 patients with both pre and post admission IBPQ score
Timeframe The data will be analyzed when there is a full dataset on 100 patients admitted from June 2020
Location of the study The Pain Centre at Zealand University Hospital, Koege
The patients will answer the questionnaire including the following data online before visiting the pain Centre and after treatment. Thereby the investigators can estimate the result of treatment compared to the BIPQ score before entry to treatment statistically. and thereby generate estimates concerning the success of pain treatment measured by BIPQ.
* The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item questionnaire, to assess the confidence people with ongoing pain have in performing activities while in pain.
* Pain during movement is measured by the Numeric Rating Scale (NRS) from 0 to 10
* For measuring the patients fear of movement related pain (fear avoidance) the 17 items questionnaire Tampa Scale of Kinesiophobia (TSK) will be used.
0= No pain at all and 10= worse imaginable pain
* Pain catastrophizing is measured by the Pain Catastrophizing Scale (PCS) and includes the following items rumination ("I can't stop thinking about how much it hurts"), magnification ("I worry that something serious may happen"), and helplessness ("There is nothing I can do to reduce the intensity of the pain"). The PCS total score is computed by summing responses to all 13 items. PCS total scores range from 0 - 52.
* Placebo measured with BIPQ. The BIPQ investigates the following; cognitive meaning (consequences, time perspective, personally control, treatment control and identity), emotional meaning (concerns, emotions), understanding of the condition and finally the patient´s own evaluation of the three most important reasons for the condition 8.
A decrease in BIPQ score will be defined as the mean +/- 1SD as cut-off.
All data will be derived from the PainData database. An examination is made of whether the patient meets the inclusion or exclusion criteria
• Data will be stored in an Excel file and the statistical analyses will performed using SPSS
Ethical aspects:
All information will be treated confidentially and all data will be anonymized by a secretary. The Investigator will keep an identification list of all patients who have been included. This list will include the patient's full name and CPR number. Collected data will be recorded in a Case Report Form. The results will be stored and analyzed using a computer and the anonymity of the patients will be preserved and local data law will be observed. Data will be stored in accordance with existing regulations. Data is stored in anonymized form and correlation and regression analysis will be performed after 6 months. The study is conducted in accordance with applicable clinical trial rules. Investigators are responsible for the handling and archiving of data in accordance with applicable rules in addition to the Act on the Processing of Personal Data and the Health Act. Data belong to the investigators. The project has been reported to the local ethic committee.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand Danish spoken and written
Exclusion Criteria
* Patients who decline to participate in the study
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anja Geisler, phd.
Role: STUDY_DIRECTOR
Koge Universitets Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zealand University Hospital
Køge, Region Sjælland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REG-1303-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.